IBTA e-News April 2019 now out

By 1st May 2019 May 31st, 2019 e-News Archive
[30 April 2019] The IBTA's monthly e-News has been released and has emailed to all subscribers. To sign up to receive your copy, click here.

You can also read the IBTA e-News April 2019 edition in full online here.

Some of the highlights from this month's round-up:

  • A study published in The Lancet Oncology has shown that artificial intelligence (AI) software can provide automated analysis of gliomas on MRI examinations. Researchers report that this technique gave more accurate assessments of how well gliomas responded to treatment than current manual methods.
  • A report in Nature Biomedical Engineering describes a bioprinting technology for placing brain tumour cells from patients onto a plastic microchip, potentially offering a way to test specific therapies in individual patients
  • According to a paper published in Science Advances, scientists have discovered a new way to measure brain function using a technology that can pick up changes in the brain as much as 60  times faster than MRI.
  • May marks Brain Tumour Awareness Month in the USA and Canada and Brain Cancer Action Month in Australia - a time when charities, groups and individuals across these countries take the opportunity to fundraise and highlight to the general public the importance of improved brain tumour research, treatment and support.
  • A (Phase 1B) clinical study involving 33 patients with newly diagnosed glioblastoma treated with a new cancer vaccine, IGV-001, has produced promising results, The vaccine is created using the patients' own tumour cells which are sampled during surgical removal of the primary brain tumour.
  • In a study published in Cancer Cell, scientists from the German Cancer Research Center (DKFZ) found that only three specific genetic alterations (gain of chromosome 7, loss of chromosome 9p and 10) appear to drive the early development of glioblastoma tumour
  • Researcher have created a new mouse model of choroid plexus carcinoma (CPC) - a brain tumour the commonly arises in infants too young for radiation therapy. It is hoped that this model will help researchers to improve their understanding of CPC biology as well as to identify and test novel drug compounds.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.